Correlations between quantitative DCE-MRI-parameters and direct tissue-based biomarkers of angiogenesis, such as vascular endothelial growth factor (VEGF) and MVD have been studied in several malignancies, including in prostate cancer, with varying results22,25–32. Here, VEGFA is linked to Familial prostate cancer.